Gene Expression Profiling of 1α,25(OH)2 D3 Treatment in 2D/3D Human Hepatocyte Models Reveals CYP3A4 Induction but Minor Changes in Other Xenobiotic-Metabolizing Genes
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
35184385
DOI
10.1002/mnfr.202200070
Knihovny.cz E-zdroje
- Klíčová slova
- CYP3A4, cytochrome P450, detoxification, gene regulation, hepatocyte, liver, metabolism, pregnane X receptor, vitamin D,
- MeSH
- cytochrom P-450 CYP3A * genetika MeSH
- hepatocyty MeSH
- lidé MeSH
- messenger RNA MeSH
- receptory kalcitriolu genetika MeSH
- stanovení celkové genové exprese MeSH
- systém (enzymů) cytochromů P-450 genetika MeSH
- vitamin D farmakologie MeSH
- xenobiotika * farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- CYP3A4 protein, human MeSH Prohlížeč
- cytochrom P-450 CYP3A * MeSH
- messenger RNA MeSH
- receptory kalcitriolu MeSH
- systém (enzymů) cytochromů P-450 MeSH
- vitamin D MeSH
- xenobiotika * MeSH
SCOPE: CYP3A4 is the most important drug-metabolizing enzyme regulated via the vitamin D receptor (VDR) in the intestine. However, less is known about VDR in the regulation of CYP3A4 and other drug-metabolizing enzymes in the liver. METHODS AND RESULTS: This study investigates whether 1α,25-dihydroxyvitamin D3 (1α,25(OH)2 D3 ) regulates major cytochrome P450 enzymes, selected phase I and II enzymes, and transporters involved in xenobiotic and steroidal endobiotic metabolism in 2D and 3D cultures of human hepatocytes. The authors found that 1α,25(OH)2 D3 increases hepatic CYP3A4 expression and midazolam 1'-hydroxylation activity in 2D hepatocytes. The results are confirmed in 3D spheroids, where 1α,25(OH)2 D3 has comparable effect on CYP3A4 mRNA expression as 1α-hydroxyvitamin D3 , an active vitamin D metabolite. Other regulated genes such as CYP1A2, AKR1C4, SLC10A1, and SLCO4A1 display only mild changes in mRNA levels after 1α,25(OH)2 D3 treatment in 2D hepatocytes. Expression of other cytochrome P450, phase I and phase II enzyme, or transporter genes are not significantly influenced by 1α,25(OH)2 D3 . Additionally, the effect of VDR activation on CYP3A4 mRNA expression is abolished by natural dietary compound sulforaphane, a common suppressor of pregnane X receptor (PXR) and constitutive androstane receptor (CAR). CONCLUSION: This study proposes that VDR or vitamin D supplementation is unlikely to significantly influence liver detoxification enzymes apart from CYP3A4.
Department of Cell Biology and Genetics Faculty of Science Palacky University Olomouc Czech Republic
Toxicogenomics Unit National Institute of Public Health Prague Czech Republic
Zobrazit více v PubMed
R. Vieth, Eur J Clin Nutr 2020, 74, 1493.
P. Pludowski, M. F. Holick, W. B. Grant, J. Konstantynowicz, M. R. Mascarenhas, A. Haq, V. Povoroznyuk, N. Balatska, A. P. Barbosa, T. Karonova, E. Rudenka, W. Misiorowski, I. Zakharova, A. Rudenka, J. Łukaszkiewicz, E. Marcinowska-Suchowierska, N. Łaszcz, P. Abramowicz, H. P. Bhattoa, S. J. Wimalawansa, J. Steroid Biochem. Mol. Biol. 2018, 175, 125.
Y. Ohyama, Front Biosci 2004, 9, 3007.
P. Lips, Prog Biophys Mol Biol 2006, 92, 4.
C. L. Taylor, C. T. Sempos, C. D. Davis, P. M. Brannon, Nutrients 2017, 9.
C. Carlberg, Vitam Horm 2016, 100, 255.
Y. Noguchi, H. Kawate, M. Nomura, R. Takayanagi, Clin Interv Aging 2013, 8, 1313.
J. D. Ringe, Arch Osteoporos 2020, 15, 182.
C. Carlberg, M. J. Campbell, Steroids 2013, 78, 127.
S. Kato, T. Morita, Clin Calcium 2015, 25, 333.
M. R. Haussler, C. A. Haussler, L. Bartik, G. K. Whitfield, J.-C. Hsieh, S. Slater, P. W. Jurutka, Nutr Rev 2008, 66, S98.
P. Pavek, Z. Dvorak, Curr. Drug Metab. 2008, 9, 129.
P. Schmiedlin-Ren, K. E. Thummel, J. M. Fisher, M. F. Paine, K. S. Lown, P. B. Watkins, Mol. Pharmacol. 1997, 51, 741.
C. Zhou, J. Clin. Invest. 2006, 116, 1703.
K. E. Thummel, C. Brimer, K. Yasuda, J. Thottassery, T. Senn, Y. Lin, H. Ishizuka, E. Kharasch, J. Schuetz, E. Schuetz, Mol. Pharmacol. 2001, 60, 1399.
P. Pavek, K. Pospechova, L. Svecova, Z. Syrova, L. Stejskalova, J. Blazkova, Z. Dvorak, J. Blahos, Biochem. Pharmacol. 2010, 79, 277.
M. Makishima, T T. Lu, W. Xie, G. K Whitfield, H. Domoto, R M. Evans, M R. Haussler, D J. Mangelsdorf, Science 2002, 296, 1313.
L. Drocourt, J.-C. Ourlin, J.-M. Pascussi, P. Maurel, M.-J. Vilarem, J. Biol. Chem. 2002, 277, 25125.
P. D. Thompson, P. W. Jurutka, G. Kerr Whitfield, S. M. Myskowski, K. R. Eichhorst, C. Encinas Dominguez, C. A. Haussler, M. R. Haussler, Biocem. Biophys. Res. Commun. 2002, 299, 730.
S. Han, J. Y. L. Chiang, Drug Metab. Dispos. 2009, 37, 469.
E. C. Y. Chow, L. Magomedova, H. P. Quach, R. Patel, M. R. Durk, J. Fan, H.-J. Maeng, K. Irondi, S. Anakk, D. D. Moore, C. L. Cummins, K. S. Pang, Gastroenterology 2014, 146, 1048.
S. Han, T. Li, E. Ellis, S. Strom, J. Y. L. Chiang, Mol. Endocrinol. 2010, 24, 1151.
H. Hara, Y. Yasunami, T. Adachi, Biochem. Biophys. Res. Commun. 2002, 296, 182.
Y. Yasunami, H. Hara, T. Iwamura, T. Kataoka, T. Adachi, Drug Metab. Dispos. 2004, 32, 685.
C.-T. Yeh, G.-C. Yen, Carcinogenesis 2005, 26, 2138.
C. Zhou, E.-J. Poulton, F. Grün, T. K. Bammler, B. Blumberg, K. E. Thummel, D. L. Eaton, Mol. Pharmacol. 2007, 71, 220.
D. Wang, L. Li, J. Fuhrman, S. Ferguson, H. Wang, Pharm. Res. 2011, 28, 2034.
L. Krausova, L. Stejskalova, H. Wang, R. Vrzal, Z. Dvorak, S. Mani, P. Pavek, Biochem. Pharmacol. 2011, 82, 1771.
R. Vrzal, A. Doricakova, A. Novotna, P. Bachleda, M. Bitman, P. Pavek, Z. Dvorak, Toxicol. Lett. 2011, 200, 146.
R. Vrzal, Z. Dvorak, Fundam. Clin. Pharmacol. 2016, 30, 585.
L. Pichard-Garcia, S. Gerbal-Chaloin, J. B. Ferrini, J. M. Fabre, P. Maurel, Methods Enzymol 2002, 357, 311.
R. M. Biancuzzo, N. Clarke, R. E. Reitz, T. G. Travison, M. F. Holick, J. Clin. Endocrinol. Metab. 2013, 98, 973.
J.-C. Souberbielle, E. Cavalier, P. Delanaye, C. Massart, S. Brailly-Tabard, C. Cormier, D. Borderie, A. Benachi, P. Chanson, Clin. Chim. Acta 2015, 451, 149.
K. Kadono, A. Koakutsu, Y. Naritomi, S. Terashita, K. Tabata, T. Teramura, Xenobiotica 2014, 44, 511.
Y. Matsuda, Y. Konno, T. Hashimoto, M. Nagai, T. Taguchi, M. Satsukawa, S. Yamashita, Pharm. Res. 2015, 32, 604.
C. C. Bell, D. F. G. Hendriks, S. M. L. Moro, E. Ellis, J. Walsh, A. Renblom, L. Fredriksson Puigvert, A. C. A. Dankers, F. Jacobs, J. Snoeys, R. L. Sison-Young, R. E. Jenkins, Å. Nordling, S. Mkrtchian, B. K. Park, N. R. Kitteringham, C. E. P. Goldring, V. M. Lauschke, M. Ingelman-Sundberg, Sci. Rep. 2016, 6, 25187.
T. Smutny, V. Bernhauerova, L. Smutna, J. D. Tebbens, P. Pavek, Arch. Toxicol. 2022, 96, 195.
P. Souček, P. Anzenbacher, I. Skoumalová, M. Dvořák, Stem Cells 2005, 23, 1417.
T. Smutny, M. Bitman, M. Urban, M. Dubecka, R. Vrzal, Z. Dvorak, P. Pavek, Arch. Toxicol. 2014, 88, 2243.
P. Pavek, L. Cerveny, L. Svecova, M. Brysch, A. Libra, R. Vrzal, P. Nachtigal, F. Staud, J. Ulrichova, Z. Fendrich, Z. Dvorak, Placenta 2007, 28, 1004.
S. P. Rhodes, J. N. Otten, G. P. Hingorani, D. P. Hartley, R. B. Franklin, J. Pharmacol. Toxicol. Methods 2011, 63, 223.
P. Pavek, Front Pharmacol 2016, 7, 456.
Z. Wang, Y. S. Lin, L. J. Dickmann, E.-J. Poulton, D. L. Eaton, J. W. Lampe, D. D. Shen, C. L. Davis, M. C. Shuhart, K. E. Thummel, J. Bone Miner. Res. 2013, 28, 1101.
T. L. Rizner, T. M. Penning, Steroids 2014, 79, 49.
G. Pan, in: X. P. Liu, G. (Ed.), Adv. Exp. Med. Biol., Springer, Singapore. 2019.
A. Pfrunder, H. Gutmann, C. Beglinger, J. Drewe, J. Pharm. Pharmacol. 2003, 55, 59.
M. Saeki, K. Kurose, M. Tohkin, R. Hasegawa, Biochem. Pharmacol. 2008, 76, 531.
X. Qin, X. Wang, Acta Pharm. Sin. B 2019, 9, 1087.
A. T. Nies, D. Keppler, The apical conjugate efflux pump ABCC2 (MRP2), Pflugers Arch 2007, 453, 643.
B. A. Kandel, M. Thomas, S. Winter, G. Damm, D. Seehofer, O. Burk, M. Schwab, U. M. Zanger, Biochim. Biophys. Acta 2016, 1859, 1218.
Y. Honjo, S. Sasaki, Y. Kobayashi, H. Misawa, H. Nakamura, J. Endocrinol. 2006, 188, 635.
T. Smutny, J. Dusek, L. Hyrsova, J. Nekvindova, A. Horvatova, S. Micuda, S. Gerbal-Chaloin, P. Pavek, Acta Pharm. Sin. B 2020, 10, 136.
V. M. Lauschke, R. Z. Shafagh, D. F. G. Hendriks, M. Ingelman-Sundberg, Biotechnol. J. 2019, 14, 1800347.
R. Adachi, Y. Honma, H. Masuno, K. Kawana, I. Shimomura, S. Yamada, M. Makishima, J. Lipid Res. 2005, 46, 46.
M. Gascon-Barré, Hepatology 2003, 37, 1034.
M. Daujat-Chavanieu, S. Gerbal-Chaloin, Cells 2020, 9.
Z. Wang, E. G. Schuetz, Y. Xu, K. E. Thummel, J. Steroid Biochem. Mol. Biol. 2013, 136, 54.
A. Giustina, R. A. Adler, N. Binkley, J. Bollerslev, R. Bouillon, B. Dawson-Hughes, P. R. Ebeling, D. Feldman, A. M. Formenti, M. Lazaretti-Castro, C. Marcocci, R. Rizzoli, C. T. Sempos, J. P. Bilezikian, Rev Endocr Metab Disord 2020, 21, 89.
L. Brandi, Nephrol Dial Transplant 2002, 17, 829.
A. M. M. Vaes, M. Tieland, M. F. De Regt, J. Wittwer, L. J. C. Van Loon, L. C. P. G. M. De Groot, Clin. Nutr. 2018, 37, 808.
M. Hewison, F. Burke, K. N. Evans, D. A. Lammas, D. M. Sansom, P. Liu, R. L. Modlin, J. S. Adams, J. Steroid Biochem. Mol. Biol. 2007, 103, 316.
R. K. Thirumaran, J. K. Lamba, R. B. Kim, B. L. Urquhart, J. C. Gregor, N. Chande, Y. Fan, A.n Qi, C. Cheng, K. E. Thummel, S. D. Hall, E. G. Schuetz, Biochem. Pharmacol. 2012, 84, 104.
J. M. Pascussi, A. Robert, M. Nguyen, O. Walrant-Debray, M. Garabedian, P. Martin, T. Pineau, J. Saric, F. Navarro, P. Maurel, M. J. Vilarem, J. Clin. Invest. 2005, 115, 177.
Y. Xu, T. Hashizume, M. C. Shuhart, C. L. Davis, W. L. Nelson, T. Sakaki, T. F. Kalhorn, P. B. Watkins, E. G. Schuetz, K. E. Thummel, Mol. Pharmacol. 2006, 69, 56.
